Germline genome sequencing samples from the Hereditary Cancer Syndromes (ICCon) Cancer Flagship
A prospective study of individuals with suspicion of a hereditary cancer syndrome for whom previous clinical targeted genetic testing was either not informative or was not available. To identify pathogenic disease-causing variants explaining participant presentation, germline whole-genome sequencing and a comprehensive cancer virtual gene panel analysis were undertaken.
- 182 samples
- DAC: EGAC00001003369
- Technology: Illumina NovaSeq 6000
Data access requests are accepted via an online application form that will require approval from the Australian Genomics Data Access Committee.
Australian Genomics participants have been asked to provide consent to share their data nationally and internationally to advance our knowledge of disease and benefit healthcare. Australian Genomics supports the sharing of de-identified genomic and clinical data from our Flagship studies for researchers with ethically approved projects. Datasets will initially be limited to our Flagships that are still completing their research analyses. However, some data are already accessible for approved secondary research use. Data access requests are accepted via an online application form that will require approval from the Australian Genomics Data Access Committee. Approved applicants will be required to abide by the Australian Genomics data policies and agreements.
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| Other |